CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis.

Valla, Marit; Klæstad, Elise; Ytterhus, Borgny; Bofin, Anna M

Valla, Marit; Klæstad, Elise; Ytterhus, Borgny; Bofin, Anna M.

Afiliação

Valla M; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Klæstad E; Clinic of Laboratory Medicine, St. Olav's Hospital, Trondheim University Hospital, 7006, Trondheim, Norway.
Ytterhus B; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Bofin AM; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

J Mammary Gland Biol Neoplasia ; 27(1): 67-77, 2022 03.

Article em En | MEDLINE | ID: mdl-35459982

Assuntos

Neoplasias da Mama; Neoplasias da Mama/genética; Neoplasias da Mama/patologia; Proteínas de Transporte/genética; Proliferação de Células/genética; Ciclina D1/genética; Feminino; Humanos; Hibridização in Situ Fluorescente; Metástase Linfática; Prognóstico

Palavras-chave

Breast cancer; CCND1; Copy number; Gene amplification; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google